Weight loss injections 'may trigger extreme gambling and divorce', chilling report warns
Researchers are urging doctors to warn patients about a potential little-known side effect of popular semaglutide drugs that ...
Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy
SPN-817 is a novel, first-in-class highly selective acetylcholinesterase (AChE) inhibitor for epilepsyCompany to host webcast today at 4:30 p.m.
PharmiWeb21h
IRLAB Strengthens its Liquidity by Drawing SEK 25 million on a Previously Secured Loan Facility
GOTHENBURG, SE / ACCESSWIRE / May 23, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 23, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and ...
2minutemedicine.com20h
Lixisenatide as a treatment for early Parkinson’s disease progression
In this randomized controlled trial, lixisenatide reduced motor disability progression in Parkinson’s patients. 2. Individuals in the lixisenatide group experienced greater gastrointestinal side ...
IRLAB Therapeutics: IRLAB Strengthens its Liquidity by Drawing SEK 25 million on a Previously Secured Loan Facility
GOTHENBURG, SE / ACCESSWIRE / May 23, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 23, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and ...